v3.0.7
Please consider this website is continuously evolving and still under development
to harmonize automatic data extraction and integrate manual data annotation.
Column | Value |
---|---|
Trial registration number | NCT04844580 |
Full text link
Last imported at : April 16, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
|
First author
Last imported at : April 16, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
|
Contact
Last imported at : April 16, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
ErdemOzdemir@centurion.com.tr |
Registration date
Last imported at : April 16, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
2021-04-14 |
Recruitment status
Last imported at : June 6, 2023, 8 a.m. Source : ClinicalTrials.gov |
Completed |
Study design
Last imported at : April 16, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
RCT |
Allocation
Last imported at : April 16, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
Randomized |
Design
Last imported at : April 16, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
Parallel |
Masking
Last imported at : April 16, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
Blind label |
Center
Last imported at : April 16, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
multi-center |
Study aim
Last imported at : April 16, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
Treatment |
Inclusion criteria
Last imported at : April 16, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
inclusion criteria: 1.18 years and older women or men, under 70 years old 2.patients with positive sars-cov-2 real time pcr result and an appearance in line with covid-19 pneumonia on thorax ct 3. need for oxygen support or spo2 <94 in room air 4. patients who can use a nebulizer (with assistance when necessary) 5.patients who are willing and capable (mentally and physically) who can sign a written informed consent form, to participate in all aspects of the study, to participate in the planned visits and to comply with the terms of the protocol. |
Exclusion criteria
Last imported at : Nov. 16, 2021, 6:30 p.m. Source : ClinicalTrials.gov |
intensive care admission the need for mechanical ventilation patients with previously known organ (kidney, heart and liver) failure * to be determined as previously known heart failure (ef <30), previously known liver failure (child-pugh c) and previously known renal failure (cr.clerance <30). covid-19 disease with no indication for hospitalization participants in another clinical trial pregnancy or lactation solid organ or stem cell transplantation story patients with collagen tissue disease use of immunosuppressive therapy procalcitonin ≥2 (baseline visit) under 18 years old those who had myocardial infarction in the last 3 months those who do not have the capacity to understand the possible results, scope and nature of the study due to legal insufficiency and / or other reasons. those who, in the opinion of the investigator, cannot continue the treatment protocol regularly or cannot cooperate presence of malignancy patients with neurological diseases |
Number of arms
Last imported at : April 16, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
2 |
Funding
Last imported at : April 16, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
Centurion Pharma |
Inclusion age min
Last imported at : April 16, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
18 |
Inclusion age max
Last imported at : April 16, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
70 |
Countries
Last imported at : April 16, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
Turkey |
Type of patients
Last imported at : April 16, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
Moderate/severe disease at enrollment |
Severity scale
Last imported at : April 16, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
4: Moderate/severe disease at enrollment |
Total sample size
Last imported at : April 16, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
80 |
primary outcome
Last imported at : April 16, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
Clinical improvement |
Notes
Last imported at : April 16, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
None |
Phase
Last imported at : April 16, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
Phase 2 |
Arms
Last imported at : April 16, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
[{"arm_notes": "Inhaled", "treatment_id": 155, "treatment_name": "Aviptadil (vasoactive intestinal peptide)", "treatment_type": "Cardiovascular agents", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}] |